Literature DB >> 31283771

Radiomics and machine learning of multisequence multiparametric prostate MRI: Towards improved non-invasive prostate cancer characterization.

Jussi Toivonen1,2, Ileana Montoya Perez1,2, Parisa Movahedi1,2, Harri Merisaari1,2,3, Marko Pesola1, Pekka Taimen4, Peter J Boström5, Jonne Pohjankukka2, Aida Kiviniemi1,6, Tapio Pahikkala2, Hannu J Aronen1,6, Ivan Jambor1,7.   

Abstract

PURPOSE: To develop and validate a classifier system for prediction of prostate cancer (PCa) Gleason score (GS) using radiomics and texture features of T2-weighted imaging (T2w), diffusion weighted imaging (DWI) acquired using high b values, and T2-mapping (T2).
METHODS: T2w, DWI (12 b values, 0-2000 s/mm2), and T2 data sets of 62 patients with histologically confirmed PCa were acquired at 3T using surface array coils. The DWI data sets were post-processed using monoexponential and kurtosis models, while T2w was standardized to a common scale. Local statistics and 8 different radiomics/texture descriptors were utilized at different configurations to extract a total of 7105 unique per-tumor features. Regularized logistic regression with implicit feature selection and leave pair out cross validation was used to discriminate tumors with 3+3 vs >3+3 GS.
RESULTS: In total, 100 PCa lesions were analysed, of those 20 and 80 had GS of 3+3 and >3+3, respectively. The best model performance was obtained by selecting the top 1% features of T2w, ADCm and K with ROC AUC of 0.88 (95% CI of 0.82-0.95). Features from T2 mapping provided little added value. The most useful texture features were based on the gray-level co-occurrence matrix, Gabor transform, and Zernike moments.
CONCLUSION: Texture feature analysis of DWI, post-processed using monoexponential and kurtosis models, and T2w demonstrated good classification performance for GS of PCa. In multisequence setting, the optimal radiomics based texture extraction methods and parameters differed between different image types.

Entities:  

Mesh:

Year:  2019        PMID: 31283771      PMCID: PMC6613688          DOI: 10.1371/journal.pone.0217702

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  48 in total

1.  SENSE: sensitivity encoding for fast MRI.

Authors:  K P Pruessmann; M Weiger; M B Scheidegger; P Boesiger
Journal:  Magn Reson Med       Date:  1999-11       Impact factor: 4.668

2.  Unsupervised texture segmentation of images using tuned matched Gabor filters.

Authors:  A Teuner; O Pichler; B J Hosticka
Journal:  IEEE Trans Image Process       Date:  1995       Impact factor: 10.856

3.  Gleason score and laterality concordance between prostate biopsy and prostatectomy specimens.

Authors:  Kenneth G Nepple; Terry L Wahls; Stephen L Hillis; Fadi N Joudi
Journal:  Int Braz J Urol       Date:  2009 Sep-Oct       Impact factor: 1.541

4.  Biexponential characterization of prostate tissue water diffusion decay curves over an extended b-factor range.

Authors:  Robert V Mulkern; Agnieszka Szot Barnes; Steven J Haker; Yin P Hung; Frank J Rybicki; Stephan E Maier; Clare M C Tempany
Journal:  Magn Reson Imaging       Date:  2006-02-20       Impact factor: 2.546

Review 5.  Computer-Aided Detection and diagnosis for prostate cancer based on mono and multi-parametric MRI: a review.

Authors:  Guillaume Lemaître; Robert Martí; Jordi Freixenet; Joan C Vilanova; Paul M Walker; Fabrice Meriaudeau
Journal:  Comput Biol Med       Date:  2015-02-20       Impact factor: 4.589

6.  New variants of a method of MRI scale standardization.

Authors:  L G Nyúl; J K Udupa; X Zhang
Journal:  IEEE Trans Med Imaging       Date:  2000-02       Impact factor: 10.048

Review 7.  An update of the Gleason grading system.

Authors:  Jonathan I Epstein
Journal:  J Urol       Date:  2009-12-14       Impact factor: 7.450

8.  Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

Authors:  Gerrit Draisma; Rob Boer; Suzie J Otto; Ingrid W van der Cruijsen; Ronald A M Damhuis; Fritz H Schröder; Harry J de Koning
Journal:  J Natl Cancer Inst       Date:  2003-06-18       Impact factor: 13.506

9.  Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Predict Gleason Score Upgrading in Intermediate-Risk 3 + 4 = 7 Prostate Cancer.

Authors:  Radu Rozenberg; Rebecca E Thornhill; Trevor A Flood; Shaheed W Hakim; Christopher Lim; Nicola Schieda
Journal:  AJR Am J Roentgenol       Date:  2016-02-02       Impact factor: 3.959

10.  Apparatus for Histological Validation of In Vivo and Ex Vivo Magnetic Resonance Imaging of the Human Prostate.

Authors:  Roger M Bourne; Colleen Bailey; Edward William Johnston; Hayley Pye; Susan Heavey; Hayley Whitaker; Bernard Siow; Alex Freeman; Greg L Shaw; Ashwin Sridhar; Thomy Mertzanidou; David J Hawkes; Daniel C Alexander; Shonit Punwani; Eleftheria Panagiotaki
Journal:  Front Oncol       Date:  2017-03-24       Impact factor: 6.244

View more
  22 in total

Review 1.  The role of radiomics in prostate cancer radiotherapy.

Authors:  Rodrigo Delgadillo; John C Ford; Matthew C Abramowitz; Alan Dal Pra; Alan Pollack; Radka Stoyanova
Journal:  Strahlenther Onkol       Date:  2020-08-21       Impact factor: 3.621

Review 2.  Radiomics: from qualitative to quantitative imaging.

Authors:  William Rogers; Sithin Thulasi Seetha; Turkey A G Refaee; Relinde I Y Lieverse; Renée W Y Granzier; Abdalla Ibrahim; Simon A Keek; Sebastian Sanduleanu; Sergey P Primakov; Manon P L Beuque; Damiënne Marcus; Alexander M A van der Wiel; Fadila Zerka; Cary J G Oberije; Janita E van Timmeren; Henry C Woodruff; Philippe Lambin
Journal:  Br J Radiol       Date:  2020-02-26       Impact factor: 3.039

3.  External validation of the computerized analysis of TRUS of the prostate with the ANNA/C-TRUS system: a potential role of artificial intelligence for improving prostate cancer detection.

Authors:  Vito Lorusso; Boukary Kabre; Geraldine Pignot; Nicolas Branger; Andrea Pacchetti; Jeanne Thomassin-Piana; Serge Brunelle; Nicola Nicolai; Gennaro Musi; Naji Salem; Emanuele Montanari; Ottavio de Cobelli; Gwenaelle Gravis; Jochen Walz
Journal:  World J Urol       Date:  2022-03-06       Impact factor: 4.226

Review 4.  Artificial intelligence and imaging for risk prediction of pancreatic cancer: a narrative review.

Authors:  Touseef Ahmad Qureshi; Sehrish Javed; Tabasom Sarmadi; Stephen Jacob Pandol; Debiao Li
Journal:  Chin Clin Oncol       Date:  2022-02-09

Review 5.  [Artificial intelligence and radiomics in MRI-based prostate diagnostics].

Authors:  Charlie Alexander Hamm; Nick Lasse Beetz; Lynn Jeanette Savic; Tobias Penzkofer
Journal:  Radiologe       Date:  2020-01       Impact factor: 0.635

6.  Value of MRI texture analysis for predicting new Gleason grade group.

Authors:  Xiaojing He; Hui Xiong; Haiping Zhang; Xinjie Liu; Jun Zhou; Dajing Guo
Journal:  Br J Radiol       Date:  2021-03-11       Impact factor: 3.039

7.  Multiple analyses suggests texture features can indicate the presence of tumor in the prostate tissue.

Authors:  Sérgio Augusto Santana Souza; Leonardo Oliveira Reis; Allan Felipe Fattori Alves; Letícia Cotinguiba Silva; Maria Clara Korndorfer Medeiros; Danilo Leite Andrade; Athanase Billis; João Luiz Amaro; Daniel Lahan Martins; André Petean Trindade; José Ricardo Arruda Miranda; Diana Rodrigues Pina
Journal:  Phys Eng Sci Med       Date:  2022-03-24

8.  Associations between Statin/Omega3 Usage and MRI-Based Radiomics Signatures in Prostate Cancer.

Authors:  Yu Shi; Ethan Wahle; Qian Du; Luke Krajewski; Xiaoying Liang; Sumin Zhou; Chi Zhang; Michael Baine; Dandan Zheng
Journal:  Diagnostics (Basel)       Date:  2021-01-07

Review 9.  Artificial Intelligence Based Algorithms for Prostate Cancer Classification and Detection on Magnetic Resonance Imaging: A Narrative Review.

Authors:  Jasper J Twilt; Kicky G van Leeuwen; Henkjan J Huisman; Jurgen J Fütterer; Maarten de Rooij
Journal:  Diagnostics (Basel)       Date:  2021-05-26

10.  Radio-pathomic mapping model generated using annotations from five pathologists reliably distinguishes high-grade prostate cancer.

Authors:  Sean D McGarry; John D Bukowy; Kenneth A Iczkowski; Allison K Lowman; Michael Brehler; Samuel Bobholz; Andrew Nencka; Alex Barrington; Kenneth Jacobsohn; Jackson Unteriner; Petar Duvnjak; Michael Griffin; Mark Hohenwalter; Tucker Keuter; Wei Huang; Tatjana Antic; Gladell Paner; Watchareepohn Palangmonthip; Anjishnu Banerjee; Peter S LaViolette
Journal:  J Med Imaging (Bellingham)       Date:  2020-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.